{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:06:53Z","timestamp":1784833613112,"version":"3.55.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"virios therapeutics, inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Animal studies have linked gastric herpesvirus infections to symptoms associated with functional gastrointestinal disorders (FGIDs). Herpesviruses have also been hypothesized to contribute to fibromyalgia (FM), a chronic pain syndrome frequently comorbid with FGIDs. The purpose of this study was to compare the prevalence of gastric herpesvirus infection in patients with FGIDs, with and without comorbid FM, to that of controls.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>For this pilot case\u2013control study, we enrolled 30 patients who met both the Rome IV diagnostic criteria for one or more FGIDs and the American College of Rheumatology 2010 criteria for FM, 15 patients with one or more FGIDs without comorbid FM, and 15 control patients. Following endoscopic examination, gastric biopsies were analyzed for herpesvirus DNA and protein, <jats:italic>Helicobacter pylori<\/jats:italic> infection, and histological evidence of gastritis. Importantly, the viral nonstructural protein ICP8 was used as a marker to differentiate cell-associated actively replicating virus from latent infection and\/or free virus passing through the GI tract.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Gastric herpes simplex virus type 1 (HSV-1) infection, as indicated by ICP8 presence, was significantly associated with FGIDs in the presence (OR 70.00, 95% CI 7.42\u2013660.50; <jats:italic>P<\/jats:italic>\u2009&lt;\u2009.001) and absence (OR 38.50, 95% CI 3.75\u2013395.40; <jats:italic>P<\/jats:italic>\u2009&lt;\u2009.001) of comorbid FM. Neither histological gastritis nor <jats:italic>H. pylori<\/jats:italic> infection were found to be associated with FGIDs or FM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>HSV-1 infection was identified in gastric mucosal biopsies from patients with diverse FGIDs, with and without comorbid FM. Larger, multi-center studies investigating the prevalence of this association are warranted.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s15010-022-01823-w","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T10:02:44Z","timestamp":1650535364000},"page":"1303-1311","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Gastric herpes simplex virus type 1 infection is associated with functional gastrointestinal disorders in the presence and absence of comorbid fibromyalgia: a pilot case\u2013control study"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3071-2303","authenticated-orcid":false,"given":"Carol","family":"Duffy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L.","family":"Pridgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Whitley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,21]]},"reference":[{"key":"1823_CR1","doi-asserted-by":"crossref","unstructured":"Duffy C, Pridgen WL, editors. 775e active herpes simplex virus type 1 infection of the gastric mucosa is associated with functional gastrointestinal disorders: a pilot case\u2013control study. American Gastroenterological Association Digestive Disease Week 2021; 2021; Virtual: Gastroenterology; 2021.","DOI":"10.1053\/j.gastro.2021.06.041"},{"key":"1823_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1176\/appi.psy.48.2.93","volume":"48","author":"MP Jones","year":"2007","unstructured":"Jones MP, Crowell MD, Olden KW, et al. Functional gastrointestinal disorders: an update for the psychiatrist. Psychosomatics. 2007;48:93\u2013102.","journal-title":"Psychosomatics"},{"key":"1823_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1136\/flgastro-2013-100426","volume":"5","author":"UN Shivaji","year":"2014","unstructured":"Shivaji UN, Ford AC. Prevalence of functional gastrointestinal disorders among consecutive new patient referrals to a gastroenterology clinic. Frontline Gastroenterol. 2014;5:266\u201371.","journal-title":"Frontline Gastroenterol"},{"key":"1823_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/ajg.2017.421","volume":"113","author":"I Aziz","year":"2018","unstructured":"Aziz I, Palsson OS, Tornblom H, et al. The prevalence and impact of overlapping Rome IV-diagnosed functional gastrointestinal disorders on somatization, quality of life, and healthcare utilization: a cross-sectional general population study in three countries. Am J Gastroenterol. 2018;113:86\u201396.","journal-title":"Am J Gastroenterol"},{"key":"1823_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12876-019-0985-1","volume":"19","author":"J Tack","year":"2019","unstructured":"Tack J, Stanghellini V, Mearin F, et al. Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries. BMC Gastroenterol. 2019;19:69.","journal-title":"BMC Gastroenterol"},{"key":"1823_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","volume":"160","author":"AD Sperber","year":"2021","unstructured":"Sperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study. Gastroenterology. 2021;160:99-114 e3.","journal-title":"Gastroenterology"},{"key":"1823_CR7","first-page":"159","volume":"3","author":"DA Drossman","year":"1990","unstructured":"Drossman DA, Thompson WG, Talley NJ, et al. Identification of sub-groups of functional gastrointestinal disorders. Gastroenterol Int. 1990;3:159\u201372.","journal-title":"Gastroenterol Int"},{"key":"1823_CR8","doi-asserted-by":"publisher","DOI":"10.24890\/pc","volume-title":"Rome IV functional gastrointestinal disorders - disorders of the gut-brain interaction","author":"DA Drossman","year":"2016","unstructured":"Drossman DA, Chang L, Chey WD, et al. Rome IV functional gastrointestinal disorders - disorders of the gut-brain interaction. 4th ed. Raleigh: The Rome Foundation; 2016.","edition":"4"},{"key":"1823_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.5056\/jnm16214","volume":"23","author":"MJ Schmulson","year":"2017","unstructured":"Schmulson MJ, Drossman DA. What is new in Rome IV. J Neurogastroenterol Motil. 2017;23:151\u201363.","journal-title":"J Neurogastroenterol Motil"},{"key":"1823_CR10","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1053\/j.gastro.2011.02.025","volume":"140","author":"PJ Pasricha","year":"2011","unstructured":"Pasricha PJ. Neurogastroenterology: a great career choice for aspiring gastroenterologists thinking about the future. Gastroenterology. 2011;140:1126\u20138.","journal-title":"Gastroenterology"},{"key":"1823_CR11","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1053\/j.gastro.2016.02.032","volume":"150","author":"DA Drossman","year":"2016","unstructured":"Drossman DA. Functional gastrointestinal disorders: history, pathophysiology. Clinical features and Rome IV. Gastroenterology. 2016;150:1262-79.e2.","journal-title":"Gastroenterology"},{"key":"1823_CR12","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1053\/j.gastro.2016.03.035","volume":"150","author":"DA Drossman","year":"2016","unstructured":"Drossman DA, Hasler WL. Rome IV-functional GI disorders: disorders of gut\u2013brain interaction. Gastroenterology. 2016;150:1257\u201361.","journal-title":"Gastroenterology"},{"key":"1823_CR13","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1136\/gutjnl-2019-320325","volume":"69","author":"M Camilleri","year":"2020","unstructured":"Camilleri M, Chedid V. Actionable biomarkers: the key to resolving disorders of gastrointestinal function. Gut. 2020;69:1730\u20137.","journal-title":"Gut"},{"key":"1823_CR14","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1001\/jama.2020.22532","volume":"325","author":"M Camilleri","year":"2021","unstructured":"Camilleri M. Diagnosis and treatment of irritable bowel syndrome: a review. JAMA. 2021;325:865\u201377.","journal-title":"JAMA"},{"key":"1823_CR15","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1056\/NEJMra1207068","volume":"367","author":"M Camilleri","year":"2012","unstructured":"Camilleri M. Peripheral mechanisms in irritable bowel syndrome. N Engl J Med. 2012;367:1626\u201335.","journal-title":"N Engl J Med"},{"key":"1823_CR16","doi-asserted-by":"publisher","first-page":"360","DOI":"10.5056\/jnm.2011.17.4.360","volume":"17","author":"H Suzuki","year":"2011","unstructured":"Suzuki H, Hibi T. Overlap syndrome of functional dyspepsia and irritable bowel syndrome\u2014are both diseases mutually exclusive? J Neurogastroenterol Motil. 2011;17:360\u20135.","journal-title":"J Neurogastroenterol Motil"},{"key":"1823_CR17","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/j.1365-2982.2012.01993.x","volume":"24","author":"SE Kim","year":"2012","unstructured":"Kim SE, Chang L. Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms? Neurogastroenterol Motil. 2012;24:895\u2013913.","journal-title":"Neurogastroenterol Motil"},{"key":"1823_CR18","doi-asserted-by":"publisher","first-page":"447","DOI":"10.5056\/jnm14080","volume":"20","author":"Y Fujiwara","year":"2014","unstructured":"Fujiwara Y, Arakawa T. Overlap in patients with dyspepsia\/functional dyspepsia. J Neurogastroenterol Motil. 2014;20:447\u201357.","journal-title":"J Neurogastroenterol Motil"},{"key":"1823_CR19","first-page":"639","volume":"31","author":"N de Bortoli","year":"2018","unstructured":"de Bortoli N, Tolone S, Frazzoni M, et al. Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders. Ann Gastroenterol. 2018;31:639\u201348.","journal-title":"Ann Gastroenterol"},{"key":"1823_CR20","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s10620-018-5343-6","volume":"64","author":"M von Wulffen","year":"2019","unstructured":"von Wulffen M, Talley NJ, Hammer J, et al. Overlap of irritable bowel syndrome and functional dyspepsia in the clinical setting: prevalence and risk factors. Dig Dis Sci. 2019;64:480\u20136.","journal-title":"Dig Dis Sci"},{"key":"1823_CR21","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S1542-3565(04)00159-4","volume":"2","author":"RC Spiller","year":"2004","unstructured":"Spiller RC. Infection, immune function, and functional gut disorders. Clin Gastroenterol Hepatol. 2004;2:445\u201355.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1823_CR22","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1053\/j.gastro.2016.12.039","volume":"152","author":"F Klem","year":"2017","unstructured":"Klem F, Wadhwa A, Prokop LJ, et al. Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis: a systematic review and meta-analysis. Gastroenterology. 2017;152:1042-54 e1.","journal-title":"Gastroenterology"},{"key":"1823_CR23","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3389\/fcimb.2020.00468","volume":"10","author":"C Carco","year":"2020","unstructured":"Carco C, Young W, Gearry RB, et al. Increasing evidence that irritable bowel syndrome and functional gastrointestinal disorders have a microbial pathogenesis. Front Cell Infect Microbiol. 2020;10:468.","journal-title":"Front Cell Infect Microbiol"},{"key":"1823_CR24","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1128\/jvi.64.5.2168-2174.1990","volume":"64","author":"JM Lohr","year":"1990","unstructured":"Lohr JM, Nelson JA, Oldstone MB. Is herpes simplex virus associated with peptic ulcer disease? J Virol. 1990;64:2168\u201374.","journal-title":"J Virol"},{"key":"1823_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1136\/gut.34.3.299","volume":"34","author":"CS Robertson","year":"1993","unstructured":"Robertson CS, Martin BA, Atkinson M. Varicella-zoster virus DNA in the oesophageal myenteric plexus in achalasia. Gut. 1993;34:299\u2013302.","journal-title":"Gut"},{"key":"1823_CR26","doi-asserted-by":"publisher","first-page":"6644","DOI":"10.3748\/wjg.v11.i42.6644","volume":"11","author":"K Tsamakidis","year":"2005","unstructured":"Tsamakidis K, Panotopoulou E, Dimitroulopoulos D, et al. Herpes simplex virus type 1 in peptic ulcer disease: an inverse association with Helicobacter pylori. World J Gastroenterol. 2005;11:6644\u20139.","journal-title":"World J Gastroenterol"},{"key":"1823_CR27","first-page":"33","volume":"72","author":"VA Krulevskii","year":"2010","unstructured":"Krulevskii VA, Petrovskii AN, Anichkov NM, et al. Chronic gastritis and herpetic infections in subjects of different ages. Arkh Patol. 2010;72:33\u20135.","journal-title":"Arkh Patol"},{"key":"1823_CR28","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3109\/00365521.2011.594083","volume":"46","author":"L Reggiani Bonetti","year":"2011","unstructured":"Reggiani Bonetti L, Losi L, Di Gregorio C, et al. Cytomegalovirus infection of the upper gastrointestinal tract: a clinical and pathological study of 30 cases. Scand J Gastroenterol. 2011;46:1228\u201335.","journal-title":"Scand J Gastroenterol"},{"key":"1823_CR29","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1007\/s10620-012-2116-5","volume":"57","author":"JL Ryan","year":"2012","unstructured":"Ryan JL, Shen YJ, Morgan DR, et al. Epstein\u2013Barr virus infection is common in inflamed gastrointestinal mucosa. Dig Dis Sci. 2012;57:1887\u201398.","journal-title":"Dig Dis Sci"},{"key":"1823_CR30","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1159\/000479232","volume":"24","author":"S Marques","year":"2017","unstructured":"Marques S, Carmo J, Pinto D, et al. Cytomegalovirus disease of the upper gastrointestinal tract: a 10-year retrospective study. GE Port J Gastroenterol. 2017;24:262\u20138.","journal-title":"GE Port J Gastroenterol"},{"key":"1823_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000479974","volume":"24","author":"E Gravito-Soares","year":"2017","unstructured":"Gravito-Soares E, Almeida N. Cytomegalovirus disease of the upper gastrointestinal tract: an emerging infection in immunocompetent hosts. GE Port J Gastroenterol. 2017;24:259\u201361.","journal-title":"GE Port J Gastroenterol"},{"key":"1823_CR32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3934\/microbiol.2018.2.225","volume":"4","author":"M Sasaki","year":"2018","unstructured":"Sasaki M, Shimizu N, Zushi Y, et al. Analysis of gastrointestinal virus infection in immunocompromised hosts by multiplex virus PCR assay. AIMS Microbiol. 2018;4:225\u201339.","journal-title":"AIMS Microbiol"},{"key":"1823_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.5152\/tjg.2020.18850","volume":"31","author":"N Dursun","year":"2020","unstructured":"Dursun N, Hacihasanoglu E, Okcu O, et al. Epstein-Barr virus infection in patients with chronic gastritis without Helicobacter pylori infection. Turk J Gastroenterol. 2020;31:205\u201310.","journal-title":"Turk J Gastroenterol"},{"key":"1823_CR34","doi-asserted-by":"publisher","first-page":"e18927","DOI":"10.1097\/MD.0000000000018927","volume":"99","author":"D Chen","year":"2020","unstructured":"Chen D, Zhao R, Cao W, et al. Clinical characteristics of cytomegalovirus gastritis: a retrospective study from a tertiary medical center. Medicine (Baltimore). 2020;99:e18927.","journal-title":"Medicine (Baltimore)"},{"key":"1823_CR35","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1128\/jvi.70.6.4097-4102.1996","volume":"70","author":"RM Gesser","year":"1996","unstructured":"Gesser RM, Koo SC. Oral inoculation with herpes simplex virus type 1 infects enteric neuron and mucosal nerve fibers within the gastrointestinal tract in mice. J Virol. 1996;70:4097\u2013102.","journal-title":"J Virol"},{"key":"1823_CR36","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1128\/jvi.71.5.4103-4106.1997","volume":"71","author":"RM Gesser","year":"1997","unstructured":"Gesser RM, Koo SC. Latent herpes simplex virus type 1 gene expression in ganglia innervating the human gastrointestinal tract. J Virol. 1997;71:4103\u20136.","journal-title":"J Virol"},{"key":"1823_CR37","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1053\/j.gastro.2010.01.036","volume":"138","author":"P Brun","year":"2010","unstructured":"Brun P, Giron MC, Zoppellaro C, et al. Herpes simplex virus type 1 infection of the rat enteric nervous system evokes small-bowel neuromuscular abnormalities. Gastroenterology. 2010;138:1790\u2013801.","journal-title":"Gastroenterology"},{"key":"1823_CR38","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s13365-011-0070-1","volume":"17","author":"JJ Chen","year":"2011","unstructured":"Chen JJ, Gershon AA, Li Z, et al. Varicella zoster virus (VZV) infects and establishes latency in enteric neurons. J Neurovirol. 2011;17:578\u201389.","journal-title":"J Neurovirol"},{"key":"1823_CR39","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.1093\/infdis\/jiy407","volume":"218","author":"M Gershon","year":"2018","unstructured":"Gershon M, Gershon A. Varicella\u2013Zoster virus and the enteric nervous system. J Infect Dis. 2018;218:S113\u20139.","journal-title":"J Infect Dis"},{"key":"1823_CR40","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/00007611-198403000-00039","volume":"77","author":"KH Rand","year":"1984","unstructured":"Rand KH, Berns KI, Rayfield MA. Recovery of herpes simplex type 1 from the celiac ganglion after renal transplantation. South Med J. 1984;77:403\u20134.","journal-title":"South Med J"},{"key":"1823_CR41","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/(SICI)1096-9071(199706)52:2<136::AID-JMV3>3.0.CO;2-4","volume":"52","author":"Y Obara","year":"1997","unstructured":"Obara Y, Furuta Y, Takasu T, et al. Distribution of herpes simplex virus types 1 and 2 genomes in human spinal ganglia studied by PCR and in situ hybridization. J Med Virol. 1997;52:136\u201342.","journal-title":"J Med Virol"},{"key":"1823_CR42","doi-asserted-by":"publisher","first-page":"e72648","DOI":"10.1371\/journal.pone.0072648","volume":"8","author":"C Zoppellaro","year":"2013","unstructured":"Zoppellaro C, Bin A, Brun P, et al. Adenosine-mediated enteric neuromuscular function is affected during herpes simplex virus type 1 infection of rat enteric nervous system. PLoS ONE. 2013;8:e72648.","journal-title":"PLoS ONE"},{"key":"1823_CR43","first-page":"1823","volume-title":"Fields virology","author":"B Roizman","year":"2013","unstructured":"Roizman B, Knipe DM, Whitley RJ. Herpes simplex viruses. In: Knipe DMHP, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B, editors. Fields virology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013. p. 1823\u201397.","edition":"6"},{"key":"1823_CR44","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.chom.2016.05.008","volume":"19","author":"W Khoury-Hanold","year":"2016","unstructured":"Khoury-Hanold W, Yordy B, Kong P, et al. Viral spread to enteric neurons links genital HSV-1 infection to toxic megacolon and lethality. Cell Host Microbe. 2016;19:788\u201399.","journal-title":"Cell Host Microbe"},{"key":"1823_CR45","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fcimb.2018.00074","volume":"8","author":"P Brun","year":"2018","unstructured":"Brun P, Qesari M, Marconi PC, et al. Herpes simplex virus type 1 infects enteric neurons and triggers gut dysfunction via macrophage recruitment. Front Cell Infect Microbiol. 2018;8:74.","journal-title":"Front Cell Infect Microbiol"},{"key":"1823_CR46","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3389\/fmed.2018.00176","volume":"5","author":"A Chaudhury","year":"2018","unstructured":"Chaudhury A, Dendi VSR, Chaudhury M, et al. HSV1\/2 genital infection in mice cause reversible delayed gastrointestinal transit: a model for enteric myopathy. Front Med (Lausanne). 2018;5:176.","journal-title":"Front Med (Lausanne)"},{"key":"1823_CR47","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2147\/JPR.S127288","volume":"10","author":"WL Pridgen","year":"2017","unstructured":"Pridgen WL, Duffy C, Gendreau JF, et al. A famciclovir + celecoxib combination treatment is safe and efficacious in the treatment of fibromyalgia. J Pain Res. 2017;10:451\u201360.","journal-title":"J Pain Res"},{"key":"1823_CR48","doi-asserted-by":"publisher","first-page":"175628482097740","DOI":"10.1177\/1756284820977402","volume":"13","author":"S Erdrich","year":"2020","unstructured":"Erdrich S, Hawrelak JA, Myers SP, et al. A systematic review of the association between fibromyalgia and functional gastrointestinal disorders. Therap Adv Gastroenterol. 2020;13:1756284820977402.","journal-title":"Therap Adv Gastroenterol"},{"key":"1823_CR49","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00296-014-3109-9","volume":"35","author":"M Slim","year":"2015","unstructured":"Slim M, Calandre EP, Rico-Villademoros F. An insight into the gastrointestinal component of fibromyalgia: clinical manifestations and potential underlying mechanisms. Rheumatol Int. 2015;35:433\u201344.","journal-title":"Rheumatol Int"},{"key":"1823_CR50","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.cgh.2008.12.005","volume":"7","author":"C Almansa","year":"2009","unstructured":"Almansa C, Rey E, Sanchez RG, et al. Prevalence of functional gastrointestinal disorders in patients with fibromyalgia and the role of psychologic distress. Clin Gastroenterol Hepatol. 2009;7:438\u201345.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1823_CR51","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","volume":"62","author":"F Wolfe","year":"2010","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010;62:600\u201310.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1823_CR52","doi-asserted-by":"crossref","unstructured":"Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161\u201381.","DOI":"10.1097\/00000478-199610000-00001"},{"key":"1823_CR53","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1155\/2001\/367832","volume":"15","author":"M Stolte","year":"2001","unstructured":"Stolte M, Meining A. The updated Sydney system: classification and grading of gastritis as the basis of diagnosis and treatment. Can J Gastroenterol. 2001;15:591\u20138.","journal-title":"Can J Gastroenterol"},{"key":"1823_CR54","doi-asserted-by":"publisher","first-page":"153","DOI":"10.32074\/1591-951X-163","volume":"112","author":"G Pennelli","year":"2020","unstructured":"Pennelli G, Grillo F, Galuppini F, et al. Gastritis: update on etiological features and histological practical approach. Pathologica. 2020;112:153\u201365.","journal-title":"Pathologica"},{"key":"1823_CR55","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1099\/0022-1317-2-3-357","volume":"2","author":"PM Ejercito","year":"1968","unstructured":"Ejercito PM, Kieff ED, Roizman B. Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. J Gen Virol. 1968;2:357\u201364.","journal-title":"J Gen Virol"},{"key":"1823_CR56","volume-title":"Molecular Cloning: A laboratory manual","author":"J Sambrook","year":"1982","unstructured":"Sambrook J, Russell DW. In: Argentine J, editor. Molecular Cloning: A laboratory manual. 3rd ed. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1982.","edition":"3"},{"key":"1823_CR57","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1128\/jcm.34.7.1666-1671.1996","volume":"34","author":"DR VanDevanter","year":"1996","unstructured":"VanDevanter DR, Warrener P, Bennett L, et al. Detection and analysis of diverse herpesviral species by consensus primer PCR. J Clin Microbiol. 1996;34:1666\u201371.","journal-title":"J Clin Microbiol"},{"key":"1823_CR58","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s11894-002-0019-x","volume":"4","author":"MK Sanders","year":"2002","unstructured":"Sanders MK, Peura DA. Helicobacter pylori-associated diseases. Curr Gastroenterol Rep. 2002;4:448\u201354.","journal-title":"Curr Gastroenterol Rep"},{"key":"1823_CR59","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1128\/CMR.00054-05","volume":"19","author":"JG Kusters","year":"2006","unstructured":"Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 2006;19:449\u201390.","journal-title":"Clin Microbiol Rev"},{"key":"1823_CR60","doi-asserted-by":"publisher","first-page":"13","DOI":"10.14218\/JERP.2016.00014","volume":"1","author":"A Barrios","year":"2016","unstructured":"Barrios A, Fernandez AB, Alvarez A, et al. Helicobacter pylori infection is associated with development of irritable bowel syndrome. J Explor Res Pharmacol. 2016;1:13\u20135.","journal-title":"J Explor Res Pharmacol"},{"key":"1823_CR61","first-page":"15","volume":"15","author":"SY Tereshchenko","year":"2017","unstructured":"Tereshchenko SY, Kasparaov EV, Prakhin EI, et al. Helicobacter pylori infection in Krasnoyarsk adolescents with functional disorders of the gastrointestinal tract. Pediatr Nutr. 2017;15:15\u201321.","journal-title":"Pediatr Nutr"},{"key":"1823_CR62","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12876-017-0723-5","volume":"18","author":"A Seid","year":"2018","unstructured":"Seid A, Tamir Z, Demsiss W. Uninvestigated dyspepsia and associated factors of patients with gastrointestinal disorders in Dessie Referral Hospital, Northeast Ethiopia. BMC Gastroenterol. 2018;18:13.","journal-title":"BMC Gastroenterol"},{"key":"1823_CR63","doi-asserted-by":"publisher","first-page":"e00405","DOI":"10.14309\/crj.0000000000000405","volume":"7","author":"Z Mungan","year":"2020","unstructured":"Mungan Z, Attila T. Dysphagia caused by Helicobacter pylori-associated inlet patch ulcer. ACG Case Rep J. 2020;7:e00405.","journal-title":"ACG Case Rep J."},{"key":"1823_CR64","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1167\/iovs.04-0614","volume":"46","author":"HE Kaufman","year":"2005","unstructured":"Kaufman HE, Azcuy AM, Varnell ED, et al. HSV-1 DNA in tears and saliva of normal adults. Invest Ophthalmol Vis Sci. 2005;46:241\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1823_CR65","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.tripleo.2007.06.011","volume":"105","author":"CS Miller","year":"2008","unstructured":"Miller CS, Danaher RJ. Asymptomatic shedding of herpes simplex virus (HSV) in the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:43\u201350.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"1823_CR66","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S0016-5107(91)70862-6","volume":"37","author":"RD McBane","year":"1991","unstructured":"McBane RD, Gross JB Jr. Herpes esophagitis: clinical syndrome, endoscopic appearance, and diagnosis in 23 patients. Gastrointest Endosc. 1991;37:600\u20133.","journal-title":"Gastrointest Endosc"},{"key":"1823_CR67","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1442-2050.2005.00510.x","volume":"18","author":"S Kato","year":"2005","unstructured":"Kato S, Yamamoto R, Yoshimitsu S, et al. Herpes simplex esophagitis in the immunocompetent host. Dis Esophagus. 2005;18:340\u20134.","journal-title":"Dis Esophagus"},{"key":"1823_CR68","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.3389\/fmicb.2018.02148","volume":"9","author":"P Brun","year":"2018","unstructured":"Brun P, Scarpa M, Marchiori C, et al. Herpes simplex virus type 1 engages toll like receptor 2 to recruit macrophages during infection of enteric neurons. Front Microbiol. 2018;9:2148.","journal-title":"Front Microbiol"},{"key":"1823_CR69","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/S0016-5085(98)70012-5","volume":"115","author":"J Tack","year":"1998","unstructured":"Tack J, Piessevaux H, Coulie B, et al. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology. 1998;115:1346\u201352.","journal-title":"Gastroenterology"},{"key":"1823_CR70","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/cch.12486","volume":"44","author":"F Jaime","year":"2018","unstructured":"Jaime F, Villagran A, Hernandez C, et al. Functional gastrointestinal disorders in children from low socio-economic status and Helicobacter pylori infection. Child Care Health Dev. 2018;44:319\u201325.","journal-title":"Child Care Health Dev"},{"key":"1823_CR71","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.3390\/ijerph17072524","volume":"17","author":"YA Kim","year":"2020","unstructured":"Kim YA, Cho YJ, Kwak SG. The association between Helicobacter pylori infection and irritable bowel syndrome: a meta-analysis. Int J Environ Res Public Health. 2020;17:2524.","journal-title":"Int J Environ Res Public Health"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-022-01823-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-022-01823-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-022-01823-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T15:10:07Z","timestamp":1666537807000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-022-01823-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,21]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1823"],"URL":"https:\/\/doi.org\/10.1007\/s15010-022-01823-w","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,21]]},"assertion":[{"value":"9 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Financial interests: CD has received research support from and served as a paid consultant to Virios Therapeutics, Inc. WLP and RJW are shareholders in Virios Therapeutics, Inc.Non-financial interests: WLP and RJW are members of the Virios Therapeutics Board of Directors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Boards of the University of Alabama and the Druid City Hospital Health System (FWA #00006291) in 2012 with annual renewals and was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. Informed consent was obtained from all study participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}